Histopathology
There are three characteristic patterns: cribriform, tubular and solid, most tumours being composed of a mix of these3. Tumour nuclei are typically small angulated and hyperchromatic; there is scanty cytoplasm.
Adenoid cystic carcinoma may undergo dedifferentiation to a high grade tumour with necrosis, a high mitotic rate and loss of the distinction between ductal and myoepithelial cells.
Immunohistochemistry
|
ductal epithelial cells |
basaloid cells (myoepithelial differentiation) |
cytokeratins |
strong0 |
weak0 |
22/226 |
||
20/202, 22/226 |
||
53/532 |
||
0/202 |
||
33/332 |
||
5/52 |
||
28/282 |
||
0/226 |
||
positive0 |
negative0 |
|
positive0 |
negative0 |
|
negative0 |
positive0 |
|
negative0 |
positive0 |
|
negative0 |
variable0 |
|
negative0 |
positive0 |
|
|
positive, membranous4 |
|
positive1 |
||
Dedifferentiated adenoid cystic carcinoma:
|
differentiated ACC |
dedifferentiated ACC |
|||
epithelium |
myoepithelium |
||||
Pankeratin |
4/47 |
4/4, focal7 |
4/47 |
||
AE1/AE3 |
2/27 |
2/2, focal7 |
2/27 |
||
Cam5.2 |
4/47 |
4/4, focal7 |
4/47 |
||
p63 |
|
7/87 |
1/8, focally in squamoid component7 |
||
Calponin |
|
1/17 |
|
||
SMA |
|
4/47 |
|
||
S100 |
6/7, focal7 |
1/77 |
6/77 |
||
CD117 |
6/67 |
|
6/67 |
||
Androgen receptor |
|
|
0/67 |
||
Her-2 |
|
|
0/67 |
||
Cytogenetics
Loss of heterozygocity at 6q23-25 is common5.
Molecular genetics
There is overexpression of genes encoding basement membrane and extracellular matrix proteins5.
Differential diagnosis
Positivity for CD43 favours adenoid cystic carcinoma.
Prognosis
Adenoid cystic carcinomas are slowly progressive with local recurrences and late metastases. Tumours with more than 30% solid pattern may have a worse prognosis3.
Management
Although adenoid cystic carcinomas are positive for CD117, tyrosine kinase receptor inhibitor has not been found to be beneficial4.
References
0Diagnostic histopathology of tumors. Edited by CDM Fletcher. 2nd edition. Churchill Livingstone. Page 269.
1 Berman, J., O'Leary, T. J. Gastrointestinal stromal tumor workshop Human Pathol 2001; 32:578-582.
2 Chu, P. G. and L. M. Weiss (2002). "Keratin expression in human tissues and neoplasms." Histopathology 40(5): 403-39. (Summary data from multiple papers)
3 Perez-Ordonez B. Selected topics in salivary gland tumour pathology. Current Diagnostic Pathology2003;9:355-365.
5 Cheuk W,Chan JK. Advances in salivary gland pathology. Histopathology 2007; 51:1-20
This page last revised 30.12.2007.